These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 22705068)

  • 21. Addition of an immunomodulator as a rescue therapy for loss of response to adalimumab dose escalation in patients with Crohn's disease.
    Papamichael K; Karatzas P; Mantzaris GJ
    J Crohns Colitis; 2015 Jul; 9(7):589-90. PubMed ID: 25863276
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunosuppressive treatment and Crohn's disease].
    Delwaide J; Louis E; Gast P; Belaiche J
    Rev Med Liege; 1991 Jan; 46(1):22-8. PubMed ID: 2011678
    [No Abstract]   [Full Text] [Related]  

  • 23. Methotrexate in Crohn's disease: results of a randomized, double-blind, placebo-controlled trial.
    Arora S; Katkov W; Cooley J; Kemp JA; Johnston DE; Schapiro RH; Podolsky D
    Hepatogastroenterology; 1999; 46(27):1724-9. PubMed ID: 10430331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methotrexate: the best choice for second-line maintenance treatment in active Crohn's disease?
    Grimaldi C
    Gastroenterol Clin Biol; 2009 Jan; 33(1 Pt 1):21-2. PubMed ID: 18977624
    [No Abstract]   [Full Text] [Related]  

  • 25. Methotrexate: first-line or second-line immunomodulator?
    Fraser AG
    Eur J Gastroenterol Hepatol; 2003 Mar; 15(3):225-31. PubMed ID: 12610315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vulval Crohn's disease: a clinical study of 22 patients.
    Laftah Z; Bailey C; Zaheri S; Setterfield J; Fuller LC; Lewis F
    J Crohns Colitis; 2015 Apr; 9(4):318-25. PubMed ID: 25687208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited?
    Charpignon C; Beau P
    Gastroenterol Clin Biol; 2008 Feb; 32(2):153-7. PubMed ID: 18343615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues.
    Weiss B; Lerner A; Shapiro R; Broide E; Levine A; Fradkin A; Bujanover Y
    J Pediatr Gastroenterol Nutr; 2009 May; 48(5):526-30. PubMed ID: 19412004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of methotrexate therapy for refractory Crohn's disease: a large single-centre experience.
    Suares NC; Hamlin PJ; Greer DP; Warren L; Clark T; Ford AC
    Aliment Pharmacol Ther; 2012 Jan; 35(2):284-91. PubMed ID: 22112005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces long-term remission in patients with steroid-refractory Crohn's disease.
    Schmidt C; Wittig BM; Moser C; Zeitz M; Stallmach A
    Aliment Pharmacol Ther; 2006 Jul; 24(2):343-50. PubMed ID: 16842461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Adalimumab vasculitis in a patient with Crohn's disease].
    Muñoz Villafranca C; Izu Belloso RM; Bravo Rodriguez MT; Basterra Olabarrieta S
    Gastroenterol Hepatol; 2013 Apr; 36(4):296-7. PubMed ID: 23522950
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of vulval Crohn's disease with infliximab.
    Preston PW; Hudson N; Lewis FM
    Clin Exp Dermatol; 2006 May; 31(3):378-80. PubMed ID: 16681581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dacryoadenitis, an extra-intestinal manifestation of Crohn's disease.
    Wong JC; Rossman D; Bressler B
    Am J Gastroenterol; 2010 Aug; 105(8):1904-6. PubMed ID: 20686473
    [No Abstract]   [Full Text] [Related]  

  • 34. Fatal Folic Acid Toxicity in Humans.
    Devnath GP; Kumaran S; Rajiv R; Shaha KK; Nagaraj A
    J Forensic Sci; 2017 Nov; 62(6):1668-1670. PubMed ID: 28261784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Methotrexate an alternative for young persons with Crohn disease].
    Hansson ME; Arebro J; Casswall T; Hessami M
    Lakartidningen; 2011 Apr 13-19; 108(15):860-3. PubMed ID: 21674974
    [No Abstract]   [Full Text] [Related]  

  • 36. Folate supplementation during methotrexate therapy for patients with psoriasis.
    Strober BE; Menon K
    J Am Acad Dermatol; 2005 Oct; 53(4):652-9. PubMed ID: 16198787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical experience of methotrexate in Crohn's disease: response, safety and monitoring of treatment.
    Parker R; Dixit A; Fraser A; Creed TJ; Probert CS
    Postgrad Med J; 2010 Apr; 86(1014):208-11. PubMed ID: 20354043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment with adalimumab in infliximab-resistant Crohn's disease.
    Barthel HR; Gille T; Halbsguth A; Kramer M
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1464-5. PubMed ID: 16105142
    [No Abstract]   [Full Text] [Related]  

  • 39. Combination therapy with methotrexate in paediatric Crohn's disease.
    Kotsiliti E
    Nat Rev Gastroenterol Hepatol; 2023 Jun; 20(6):344. PubMed ID: 37085618
    [No Abstract]   [Full Text] [Related]  

  • 40. Methotrexate Pneumonitis in Crohn's Disease: A Rare Case Report and Review of Literature.
    Sánchez A; Ramírez de la Piscina P; Duca I; Estrada S; Calderón R; Salvador M; Delgado E; García Campos F
    Arch Bronconeumol (Engl Ed); 2018 Oct; 54(10):535-536. PubMed ID: 29503065
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.